Evelo Biosciences OverviewLatest profit margin for Evelo Biosciences: -Infinity% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2023
Trailing 12 months ending Sep 2023
As of the most recent data (September 2023), EVLO shows a profit margin of -Infinity%. That is below the Healthcare sector average of 15.58%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average profit margin is about 15.58%. Evelo Biosciences is at -Infinity%, which is lower that average. That is roughly Infinity% below the sector mean. Use the comparison chart on this page to see how EVLO stacks up against individual peers as well.
Check the historical chart to see whether EVLO's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Evelo Biosciences with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Evelo Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -Infinity%) with ownership activity and broader fundamentals.
The Healthcare average profit margin is about 15.58%, while EVLO is at -Infinity%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
